Form 4 for AURA Aura Biosciences, Inc.
Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-20 · accession 0001193125-26-016939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | 2026-01-20 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $4.86 | -1,581 | 84.1K | -2% | -$7,684 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | S | D | 1,581 | $4.86 | 84,081 | D | — | — |